# Elena Élez

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/elena-elez/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,209 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 58 |
| i10-index | 160 |
| Last Known Institution | Vall d'Hebron Hospital Universitari |
| OpenAlex ID | https://openalex.org/A5030657436 |
| ORCID iD | https://orcid.org/0000-0002-4653-6324 |
| Works | 582 |

## Researcher papers

- [Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer](https://scholariq.org/papers/encorafenib-binimetinib-and-cetuximab-in-i-braf-i-v600e-mutated-colorectal/)
- [Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial](https://scholariq.org/papers/dabrafenib-plus-trametinib-in-patients-with-brafv600e-mutated-biliary-tract/)
- [Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer](https://scholariq.org/papers/trifluridine-tipiracil-and-bevacizumab-in-refractory-metastatic-colorectal/)
- [Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study](https://scholariq.org/papers/fruquintinib-versus-placebo-in-patients-with-refractory-metastatic-colorectal/)
- [Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma](https://scholariq.org/papers/safety-and-antitumor-activity-of-the-anti-pd-1-antibody-pembrolizumab-in/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Vall d'Hebron Hospital Universitari](https://scholariq.org/institutions/vall-d-hebron-hospital-universitari/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.